Aleve, Vioxx, Celebrex, and Bextra: What You Need to Know About Arthritis Pain Medications

Written by R.L. Fielding


Continued from page 1

FDA Directive: Stronger Warning Labels for Some Pain Medications

On April 7, 2005, taking into accountrepparttar recommendations ofrepparttar 137145 Advisory Committee,repparttar 137146 FDA issuedrepparttar 137147 following directives:

•Bextra, a COX-2 specific inhibitor manufactured by Pfizer, was withdrawn fromrepparttar 137148 market.

•All prescription NSAIDs must revise their labeling to include a “black box” warning that highlightsrepparttar 137149 potential increased risk for cardiovascular (CV) events as well asrepparttar 137150 potentially life threatening gastrointestinal (GI) bleeding associated with these drugs. Celebrex,repparttar 137151 only COX-2 specific inhibitor remaining onrepparttar 137152 US market, was included in this directive.

•All OTC NSAIDs (except aspirin) will be required to revise their labeling to include more specific information aboutrepparttar 137153 potential for GI and CV side effects, a stronger reminder to follow label instructions, as well as a warning about potential skin reactions.

To further evaluaterepparttar 137154 potential for increased CV risk,repparttar 137155 FDA also announced that all NSAIDs must conduct and submit torepparttar 137156 FDA a comprehensive review and analysis of pertinent safety data from clinical trials.

•Aleve (naproxen sodium) is supported by clinical studies conducted to gain approval of naproxen as a prescription product and as OTC that do not provide any evidence of increased risk of cardiovascular events.

Treatment Options: What Should Arthritis Patients Know?

For some people who suffer from pain associated with arthritis, their symptoms can be managed with exercise, heat/cold therapy, joint protection, assistive devices, weight control, or in some severe cases, surgery. For others, medications are needed to help managerepparttar 137157 symptoms associated with arthritis.

When taken as directed OTC medications such as Aleve provide a safe and effective way to treat mild to moderate pain of minor arthritis. If patients have questions, they should consult their health care professional about which treatment option is most appropriate.

Why It’s Important to Treat Arthritis

Arthritis affects approximately 66 million Americans and isrepparttar 137158 nation’s leading cause of disability. There are over 100 different types of arthritis, and they all have different symptoms that vary in severity from person to person. The most common form of arthritis, osteoarthritis, is characterized byrepparttar 137159 breakdown of cartilage that causesrepparttar 137160 bones to rub together, resulting in pain, loss of movements and stiffness . Arthritis is usually a chronic condition.

For more information on Aleve and naproxen, visitrepparttar 137161 Aleve website at www.aleve.com. For more information on arthritis pain relief, visit www.arthritis.org.



R.L. Fielding writes on a number of subjects.


Saffola: You'll go where your lifestyle leads

Written by Shailendra Katyal


Continued from page 1

A monthly newsletter ‘H-files,’ brings recipients a compliation of wellness breakthroughs, no-nonsense health articles, effective fitness tips and global health news, right to their mailbox. It will also communicaterepparttar brand’s health-related ground activites with partner organisations inrepparttar 137099 healthy lifestyle arena.

Saffola Life Parry Nutraceuticals Marketics Technologies Infotronics Exind Fabrics

Brand Manager RANG SHARDA, K.C. Marg, Bandra Reclamation, Bandra(w), Mumbai - 400 050 Tel: 91 022 56480480 Fax: 91 022 5649 0113 Mobile: 9820953484


    <Back to Page 1
 
ImproveHomeLife.com © 2005
Terms of Use